South Africa new coronavirus variant rages alongside vaccine finance debate

South Africa’s struggle with a new variant of Covid-19 coincides with a debate over how and who will pay for the vaccine. The business community may be one part of the solution, with the government saying the Pfizer jab is too expensive.


Leave a Reply